I am sorry that I have not posted anything recently, but I have just returned from Atlanta Georgia where I was an invited guest at a conference sponsored by the American Cancer Society, The Lance Armstrong Foundation and the National Cancer Institute. The conference was a biannual event focused on survivor research. The sponsors of [...]
The Prostate Cancer Foundation (PCF) is the world’s largest philanthropic source of support for prostate cancer research with the goal of discovering better treatments leading to a cure specifically for recurrent prostate cancer. I believe that the PCF is the only organization that has as its focus the treatment of and finding a curing for [...]
Increasingly, we are finding pressure from the insurance world to demonstrate that the treatments we go through are the best available, meaning the most cost effective and yielding the best results. Research into prostate cancer is lagging and has not relied on evidence based results. Treatment decisions are often made on nonscientific consensus of the [...]
At the recent American Association of Cancer Researchers (AACR,) there was a shocking poster presentation that demonstrated that mice that exercised experienced implanted prostate cancer tumor grow that was twice as fast than did those mice who were restricted from exercising! The study was conducted by the Duke Comprehensive Cancer Center (DCCC) and the Duke [...]
In the United Kingdom cancer patients who are terminal have the opportunity to take experimental drugs long before they would be allowed to in the United States. The UK Department of Health has authorized a network of 19 hospitals where patients who have no other hope of a cure can agree to take drugs which [...]
There is exciting news out of the 2008 Genitourinary Cancers Symposium in San Francisco. An abstract (American Society of Clinical Oncology 2008 Genitourinary Cancers Symposium (GCS): Abstract 85) presented at the conference described a retrospective study that strongly suggests that salvage radiotherapy reduced the risk of dying from prostate cancer by more than 60% for [...]
Those of us in the prostate cancer world know that our disease presents us with many contradictions. Our dietary and suggested supplement recommendations seem to be modified as often as the wind changes direction. Even more serious is our lack of good tumor markers for disease progression. The result is we are forced to make [...]
This morning’s New York Times on-line carried an interesting story written by Gina Kolata about what could be the next wave of cancer research, cancerous stem cells (csc). Despite the common belief that cancerous cells can just continue to divide and divide forever, now some researchers believe that cancerous tumor cells are, just as normal [...]
Dr. Clinton T. Rubin, Ph.D., Distinguished Professor and Director for Center for Biotechnology at the State University of New York at Stony Brook, is reporting that mice placed on a platform that buzzes for 15 minutes a day, five days a week have 27 percent less fat than mice that did not stand on the [...]
Often, the FDA limits access to clinical trials to patients who have failed all other approved therapies. This means that we only evaluate potential new drugs on individuals who are already very sick and have been weakened by their disease as well as their prior treatments. Cancer cells "learn" how to survive treatments by mutating. [...]
